Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05404945 |
|---|---|
| Brief Title: | Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above |
| First Submitted : | May 22, 2022 |
| First Submitted that Met QC Criteria : | May 31, 2022 |
| First Posted : | June 3, 2022 |
| Last Update Submitted that Met QC Criteria : | July 27, 2022 |
| Last Update Posted : | July 29, 2022 |